CoChat
Sign Up
Cited by 107Smoking Behavior and CessationSubstance Abuse Treatment and OutcomesHIV/AIDS Research and Interventions

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

A Randomized Controlled Trial of a Tailored Group Smoking Cessation Intervention for HIV-Infected Smokers

Open access
Moadel, Alyson B., Bernstein, Steven L., Mermelstein, Robin J., Arnsten, Julia H., Dolce, Eileen H., Shuter, Jonathan·2012·JAIDS Journal of Acquired Immune Deficiency Syndromes
DOI 10.1097/qai.0b013e3182645679PMC PMC3568498
Open this paper in CoChat — free account

Abstract

BACKGROUND: More than half of the persons living with human immunodeficiency virus (HIV; PLWH) in the US smoke cigarettes, and tobacco use is responsible for considerable morbidity and mortality in this group. Little is known about the efficacy of tobacco treatment strategies in PLWH. DESIGN: Randomized controlled trial comparing Positively Smoke Free (PSF), an intensive group-therapy intervention targeting HIV-infected smokers, to standard care. METHODS: A cohort of 145 PLWH smokers, recruited from an HIV-care center in the Bronx, New York, were randomized 1:1 into the PSF program or standard care. All were offered a 3-month supply of nicotine replacement therapy. PSF is an 8-session program tailored to address the needs and concerns of HIV-infected smokers. The sessions were cofacilitated by a graduate student and an HIV-infected peer. The primary outcome was biochemically confirmed, 7-day point-prevalence abstinence at 3 months. RESULTS: In the intention-to-treat analysis, PSF condition subjects had nearly double the quit rate of controls (19.2% vs. 9.7%, P = 0.11). In the complete case, as-treated analysis, assignment to PSF was associated with increased odds of quitting (odds ratio(adj) 3.55, 95% confidence interval 1.04 to 12.0). Latino ethnicity and lower loneliness score were predictive of abstinence. The subjects in the PSF condition exhibited significant decreases in daily cigarette consumption and significant increases in self-efficacy and in motivation to quit. Attendance of ≥7 sessions was associated with higher quit rates. CONCLUSIONS: These findings suggest a positive effect of PSF on cessation rates in PLWH smokers. Loneliness and self-efficacy are influential factors in the smoking behaviors of PLWH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/qai.0b013e3182645679

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

Sorted by citations

See all 107

Related

See all

Metadata

Authors
Moadel, A. B., Bernstein, S. L., Mermelstein, R. J., Arnsten, J. H., Dolce, E. H., & Shuter, J.
Affiliations
  • Albert Einstein College of Medicine (US)
  • Yale University (US)
  • University of Illinois Chicago (US)
Corresponding author
Moadel, Alyson B.
ORCID
Venue
JAIDS Journal of Acquired Immune Deficiency Syndromes
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2012-10-01
Volume
61
Issue
2
Pages
208-215
ISSN
1525-4135 (ISSN-L)
DOI
10.1097/qai.0b013e3182645679
PMC
PMC3568498
OpenAlex
W2024488929
Semantic Scholar
837e8b3743aa5d391cff7732802dcfa7a3b697ec
Cited by
107
References
41
Citations by year
2026: 4 · 2025: 3 · 2024: 9 · 2023: 5 · 2022: 2 · 2021: 10 · 2020: 5 · 2019: 8 · 2018: 7 · 2017: 8 · 2016: 16 · 2015: 9 · 2014: 11 · 2013: 8 · 2012: 2
FWCI
6.43
Type
journal article
Language
en
Open access
Locations
  • JAIDS Journal of Acquired Immune Deficiency Syndromes (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Drug Abuse (R21DA023362)
  • National Cancer Institute (R21CA163100)
  • National Institute of Allergy and Infectious Diseases (AI-51519, P30AI051519)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
smoking cessation, group therapy, nicotine replacement therapy, peer facilitation, abstinence, loneliness, self-efficacy, Hispanic origin, Latino smokers
MeSH terms
Adult, Aged, Female, Humans, Male, Middle Aged, New York, Smoking, HIV Infections, Smoking Cessation, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review